Return-Path: <training-HP2v400000162d40d3d65c94d356e966f45e8214@info.grcseminars.com>
Delivered-To: charley@transocean.com
Received: from vps.transocean.com
	by vps.transocean.com with LMTP id aGSrKLIH1lq6UAAAInt2oQ
	for <charley@transocean.com>; Tue, 17 Apr 2018 07:41:54 -0700
Return-path: <training-HP2v400000162d40d3d65c94d356e966f45e8214@info.grcseminars.com>
Envelope-to: charley@transocean.com
Delivery-date: Tue, 17 Apr 2018 07:41:54 -0700
Received: from mta036b.pmx1.epsl1.com ([142.54.244.36]:53287)
	by vps.transocean.com with esmtp (Exim 4.89_1)
	(envelope-from <training-HP2v400000162d40d3d65c94d356e966f45e8214@info.grcseminars.com>)
	id 1f8Rnn-0005br-Hm
	for charley@transocean.com; Tue, 17 Apr 2018 07:41:54 -0700
DKIM-Signature: v=1; a=rsa-sha256; c=simple/simple; d=info.grcseminars.com;
	s=ep1; t=1523976060;
	bh=Y2VlV2p63VJWzTTmFeVH/6nyK7Nh1sx07UI30jQdWeU=;
	h=MIME-Version:Subject:From:To:Date:Content-Type;
	b=en62+ewc/uefuWiDWaRYJNGnQgh9wZwBtivfhqePqybPFWAF7mwWUjFE+SXjprhZ2
	 ZixUT01Z456Nje0gz8QUQvxML7o1N04e0GG7O+/bZslYgy9psqF1pjAvEBIyqaFNf0
	 2wmQHCH+ViioSyjKbYvOrhqw0CmFkFaEiQOrE6PY=
Received: from [10.233.18.116] ([10.233.18.116:43026])
	by pc1udsmtn1n12 (envelope-from <training-HP2v400000162d40d3d65c94d356e966f45e8214@info.grcseminars.com>)
	(ecelerity 3.6.9.48312 r(Core:3.6.9.0)) with ECSTREAM
	id 89/C5-43926-C7706DA5; Tue, 17 Apr 2018 14:41:00 +0000
List-Unsubscribe: <mailto:training-HP2v400000162d40d3d65c94d356e966f45e8214@info.grcseminars.com?subject=list-unsubscribe>
Message-ID: <HP2v400000162d40d3d65c94d356e966f45e8214@info.grcseminars.com>
MIME-Version: 1.0
Reply-To: "training@info.grcseminars.com"
 <training-HP2v400000162d40d3d65c94d356e966f45e8214@info.grcseminars.com>
Subject: FDA Post Market Regulations | Workshop by Ex-FDA Officials
From: GRC Seminars  <training@info.grcseminars.com>
To: charley@transocean.com
Date: Tue, 17 Apr 2018 14:41:00 +0000
Content-Type: multipart/alternative;
 boundary="-=Part.1a3a6b0.5521f224a14f7942.162d40d402d.c70772e38745b82f=-"
X-Spam-Status: No, score=2.2
X-Spam-Score: 22
X-Spam-Bar: ++
X-Ham-Report: Spam detection software, running on the system "vps.transocean.com",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 
 Content preview:  GRC Seminars GRC Seminars +1-888-771-6965 Understanding FDA
    Post Market Regulations 3-Day Workshop by Ex-FDA Officials By: Casper E.
   Uldriks & Rita Hoffman | San Francisco, CA | May 23-24-25, 2018 VIEW AGENDA
    Former FDA Directors will explain how participants can mitigate the risk
   of regulatory enforcement actions; avoid future recalls by using the Total
    Product Life Cycle TPLC paradigm that CDRH uses. Course materials include
    creating Standard Operating Systems for Post-Market Quality Systems, how
   risk guidance document intertwines with Recalls and ORA Inspection Realignment
    Structure. This Seminar will have you stop spinning your wheels with nonessential
    activities, and leave you with a comprehensive learning package that has
   only been offered by Casper Uldriks and Rita Hoffman, who bring over 68 years
    of combined experience. Learning Objectives: Learn about the FDA's agency-wide
    legal and procedural steps and investigational operations for post market
    issues Understand how to comply with complicated Compliant Handling, MDR
   and Recall requirements Firms MDR reporting and FDA's handling of MDR reports
    Company preparation in the event of a Recall, recall strategy, notification
    letter and communicating with the FDA Minimize your risk of regulatory enforcement
    actions Assist with the creation and maintenance of effective procedures
   for handling complaints, reportable events and recalls Understand the relationship
    and interaction with other quality system elements as they relate to complaints
    and reportable events Walk-through of case examples Step-By-Step guide to
    designing Standard Operating Systems for communicating process for firm's
    success Discussion of FDA's New Guidance's on Risk and how it interacts with
    Recalls Meet Your Instructors: [...] 
 
 Content analysis details:   (2.2 points, 3.0 required)
 
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.0 URIBL_BLOCKED          ADMINISTRATOR NOTICE: The query to URIBL was blocked.
                             See
                             http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
                              for more information.
                             [URIs: grcseminars.com]
 -0.0 SPF_PASS               SPF: sender matches SPF record
  0.0 HTML_MESSAGE           BODY: HTML included in message
  0.8 BAYES_50               BODY: Bayes spam probability is 40 to 60%
                             [score: 0.5000]
  0.8 MPART_ALT_DIFF         BODY: HTML and text parts are different
  0.7 MIME_HTML_ONLY         BODY: Message only has text/html MIME parts
 -0.1 DKIM_VALID             Message has at least one valid DKIM or DK signature
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily valid
 -0.1 DKIM_VALID_AU          Message has a valid DKIM or DK signature from author's
                             domain
  0.0 MIME_HTML_ONLY_MULTI   Multipart message only has text/html MIME parts
X-Spam-Flag: NO

---=Part.1a3a6b0.5521f224a14f7942.162d40d402d.c70772e38745b82f=-
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=UTF-8

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1=2E0 Transitional//EN" "https://w=
ww=2Ew3=2Eorg/TR/xhtml1/DTD/xhtml1-transitional=2Edtd">

<html xmlns=3D"https://www=2Ew3=2Eorg/1999/xhtml">

<head>

<meta http-equiv=3D"Content-Type" content=3D"text/html; Channelarset=3Dutf=
-8" />

<title>GRC Seminars</title>

</head>

=20

<body style=3D"background-color:#F2F2F2;">
<table width=3D"100%" cellspacing=3D"0" cellpadding=3D"0" border=3D"0">
<tbody>
<tr>
<td align=3D"center"><br />
<table style=3D"max-width: 650px; min-width: 300px; -webkit-text-size-adju=
st: 100%; border: #ACACAC solid 1px;" width=3D"650" cellspacing=3D"0" cellp=
adding=3D"0" border=3D"0">
<tbody>
<tr>
<td style=3D"padding: 8px 20px 20px 20px;" bgcolor=3D"#FFFFFF">
<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" bgcolor=3D"#ffffff=
" align=3D"center">
<tbody>
<tr>
<td width=3D"650">
<table width=3D"100%" cellspacing=3D"0" cellpadding=3D"5" border=3D"0">
<tbody>
<tr>
<td valign=3D"top">
<table width=3D"100%" cellspacing=3D"0" cellpadding=3D"0" border=3D"0">
<tbody>
<tr>
<td style=3D"font-family: Arial, Helvetica, sans-serif;" valign=3D"middle"=
><span style=3D"color: #ff5733; font-size: 28px;">GRC</span><span style=3D"=
font-family: Arial, Helvetica, sans-serif; font-size: 28px; color: #444444;=
"> Seminars<br /> </span></td>
<td colspan=3D"2" valign=3D"middle" align=3D"right"><span style=3D"font-fa=
mily: Arial, Helvetica, sans-serif; font-size: 18px;"><strong>+1-888-771-69=
65</strong></span></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td style=3D"border-bottom: 2px solid #acacac;" valign=3D"top" height=3D"3=
" align=3D"left"></td>
</tr>
<tr>
<td style=3D"font-family: Arial, Helvetica, sans-serif; color: #444444; ba=
ckground-color: #eeeeee; font-size: 21pt;" valign=3D"top" align=3D"center">=
<strong>Understanding FDA Post Market Regulations</strong><br /><span style=
=3D"font-size: 18=2E0pt; font-weight: bold;"><em><strong>3-Day Workshop by =
Ex-FDA Officials</strong></em></span></td>
</tr>
<tr>
<td style=3D"font-family: Arial, Helvetica, sans-serif; background-color: =
#eeeeee; color: #444444; font-size: 11=2E5pt; padding-bottom: 10px;" valign=
=3D"top" align=3D"center"><strong>By: <u>Casper E=2E Uldriks &amp; Rita Hof=
fman</u> | San Francisco, CA | May 23-24-25, 2018</strong></td>
</tr>
<tr>
<td style=3D"font-family: Arial, Helvetica, sans-serif; color: #ffffff; ba=
ckground-color: #ea501e; font-size: 11=2E5pt; line-height: 18=2E0pt;" heigh=
t=3D"24" align=3D"center"><a href=3D"http://info=2Egrcseminars=2Ecom/T/v400=
000162d40d3d65c94d356e966f45e8/61c9a141ece3493c0000021ef3a0bcc2/61c9a141-ec=
e3-493c-acfe-e7c828b61f46" target=3D"_blank&quot;" style=3D"color: #ffffff;=
 text-decoration: none;"><strong>VIEW AGENDA</strong></a></td>
</tr>
<tr>
<td valign=3D"top" height=3D"10" align=3D"left"></td>
</tr>
<tr>
<td style=3D"font-family: Arial, Helvetica, sans-serif; color: #444444; fo=
nt-size: 11=2E5pt; line-height: 18=2E0pt; padding-left: 15px; padding-right=
: 15px;" valign=3D"top" height=3D"" align=3D"left">Former FDA Directors wil=
l explain how participants can mitigate the risk of regulatory enforcement =
actions; avoid future recalls by using the Total Product Life Cycle TPLC pa=
radigm that CDRH uses=2E Course materials include creating Standard Operati=
ng Systems for Post-Market Quality Systems, how risk guidance document inte=
rtwines with Recalls and ORA Inspection Realignment Structure=2E This Semin=
ar will have you stop spinning your wheels with nonessential activities, an=
d leave you with a comprehensive learning package that has only been offere=
d by Casper Uldriks and Rita Hoffman, who bring over 68 years of combined e=
xperience=2E</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td style=3D"font-family: Arial, Helvetica, sans-serif; color: #444444; fo=
nt-size: 11pt; padding: 26px 35px 20px 35px; border-top: 1px solid #d1d1d1;=
 border-bottom: 1px solid #d1d1d1; line-height: 20px; background-color: #f6=
f6f6;"><strong style=3D"font-size: 13pt;">Learning Objectives:</strong>
<ul style=3D"font-family: Arial, Helvetica, sans-serif; color: #444444; fo=
nt-size: 11=2E5pt; line-height: 22px;">
<li>Learn about the FDA's agency-wide legal and procedural steps and inves=
tigational operations for post market issues</li>
<li>Understand how to comply with complicated Compliant Handling, MDR and =
Recall requirements</li>
<li>Firms MDR reporting and FDA's handling of MDR reports</li>
<li>Company preparation in the event of a Recall, recall strategy, notific=
ation letter and communicating with the FDA</li>
<li>Minimize your risk of regulatory enforcement actions</li>
<li>Assist with the creation and maintenance of effective procedures for h=
andling complaints, reportable events and recalls</li>
<li>Understand the relationship and interaction with other quality system =
elements as they relate to complaints and reportable events</li>
<li>Walk-through of case examples</li>
<li>Step-By-Step guide to designing Standard Operating Systems for communi=
cating process for firm's success</li>
<li>Discussion of FDA's New Guidance's on Risk and how it interacts with R=
ecalls</li>
</ul>
</td>
</tr>
<tr>
<td style=3D"font-family: Arial, Helvetica, sans-serif; color: #444444; fo=
nt-size: 11=2E5pt; background-color: #ffffff; padding: 8px 35px 10px 35px; =
line-height: 20px;"><br /><strong style=3D"font-size: 12pt;">Meet Your Inst=
ructors: </strong> <br />
<p><span style=3D"color: #ff5733;"><b>Casper Uldriks</b></span>, <i>Former=
 Associate Center Director of FDA's CDRH</i></p>
<p>Seminar Instructor Casper Uldriks is an "Ex-FDA Official" who has spent=
 32 years in FDA and his engagements focus on advertising and promotion, re=
calls, corrections and removals and enforcement=2E He understands how FDA t=
hinks, how it operates and where it is headed=2E Based on his exceptionally=
 broad experience and knowledge, he can synthesize FDA=E2=80=99s domestic a=
nd international operational programs, institutional policy and thicket of =
legal variables into a coherent picture=2E</p>
<p><span style=3D"color: #ff5733;"><b>Rita Hoffman </b></span>, <i>RAC, Ma=
naging Partner Regs, Former FDA CDRH Recall Branch Chief=2E</i></p>
<p>Rita Hoffman retired from the FDA in January 2011 as the Recall Branch =
Chief for the Center for Devices and Radiological Health (CDRH), where she =
was responsible for oversight and review for all medical device recalls=2E =
Ms=2E Hoffman held several positions including the Center for Drug Evaluati=
on and Research (CDER) Jurisdiction Review Officer (providing guidance on d=
rug/device product designation, combination products and co-packaging), Act=
ing Associate Ombudsman, Small Business Liaison, and was a Policy Analyst f=
or eight years in the Office of the Commissioner=2E</p>
</td>
</tr>
<tr></tr>
<tr>
<td style=3D"font-family: Arial, Helvetica, sans-serif; background-color: =
#ea501e; font-size: 11=2E5pt; line-height: 18=2E0pt;" height=3D"34" align=
=3D"center"><a href=3D"http://info=2Egrcseminars=2Ecom/T/v400000162d40d3d65=
c94d356e966f45e8/61c9a141ece3493c0000021ef3a0bcc3/61c9a141-ece3-493c-acfe-e=
7c828b61f46" target=3D"_blank" rel=3D"noopener noreferrer" style=3D"color: =
#ffffff; text-decoration: none;"><strong>View Details</strong></a></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<table style=3D"width: 650px; -webkit-text-size-adjust: 100%;" cellspacing=
=3D"0" cellpadding=3D"0" border=3D"0" align=3D"center">
<tbody>
<tr>
<td style=3D"color: #999999; font-size: 8=2E5pt; font-family: Arial, Helve=
tica, sans-serif; line-height: 16=2E1pt;" valign=3D"bottom" height=3D"55" a=
lign=3D"center">=C2=A9 Copyright 2018 | 2479 East Bayshore Road, Suite 200 =
Palo Alto, CA 94303, USA | +1-888-771-6965<br /> <span style=3D"font-size: =
11px;">This message was sent to charley@transocean=2Ecom | <a href=3D"http:=
//info=2Egrcseminars=2Ecom/U/v400000162d40d3d65c94d356e966f45e8/61c9a141ece=
3493c0000021ef3a0bcc4">Unsubscribe</a>=2E</span></td>
</tr>
</tbody>
</table>

<img src=3D'http://info=2Egrcseminars=2Ecom/O/v400000162d40d3d65c94d356e96=
6f45e8/61c9a141ece3493c00004c5a42963aa1' style=3D"display:none; max-height:=
 0px; font-size: 0px; overflow: hidden; mso-hide: all"/></body>

</html>
---=Part.1a3a6b0.5521f224a14f7942.162d40d402d.c70772e38745b82f=---

